Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Goodkin

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Kidney International|May 30, 2015
Intravenous iron dose and mortality in hemodialysis patientsDavid A Goodkin, George R Bailie
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2015
Intravenous iron, inflammation, and ventricular dysfunction during hemodialysisDavid A Goodkin, George R Bailie
Cytokines, Cellular & Molecular Therapy|February 28, 2003
Pharmacologic and cytokine treatment of commonly encountered anemiasMaryAnn Foote, Alan Colowick, David A Goodkin
The New England Journal of Medicine|January 25, 2008
The normal hematocrit study--follow-upAnatole Besarab, David A Goodkin, Allen R Nissenson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 14, 2011
Iron and calciphylaxisDavid A Goodkin, Maria Larkina, Bruce M Robinson
Kidney International|January 26, 2020
The authors replyMichel Jadoul, Brian A Bieber, David A Goodkin, et al.
American Journal of Nephrology|April 24, 2022
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically TransientDavid A Goodkin, Junhui Zhao, Aleix Cases, et al.
Blood Purification|August 4, 2011
Absence of anemia in hemodialysis patientsDavid A Goodkin, Douglas S Fuller, Bruce M Robinson, et al.
American Journal of Nephrology|November 7, 2013
Hepatitis C infection is very rarely treated among hemodialysis patientsDavid A Goodkin, Brian Bieber, Brenda Gillespie, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 22, 2010
Hemodialysis vascular access training and practices are key to improved access outcomesDavid A Goodkin, Ronald L Pisoni, Francesco Locatelli, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Kidney International|May 30, 2015
Intravenous iron dose and mortality in hemodialysis patientsDavid A Goodkin, George R Bailie
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2015
Intravenous iron, inflammation, and ventricular dysfunction during hemodialysisDavid A Goodkin, George R Bailie
Cytokines, Cellular & Molecular Therapy|February 28, 2003
Pharmacologic and cytokine treatment of commonly encountered anemiasMaryAnn Foote, Alan Colowick, David A Goodkin
The New England Journal of Medicine|January 25, 2008
The normal hematocrit study--follow-upAnatole Besarab, David A Goodkin, Allen R Nissenson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 14, 2011
Iron and calciphylaxisDavid A Goodkin, Maria Larkina, Bruce M Robinson
Kidney International|January 26, 2020
The authors replyMichel Jadoul, Brian A Bieber, David A Goodkin, et al.
American Journal of Nephrology|April 24, 2022
Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically TransientDavid A Goodkin, Junhui Zhao, Aleix Cases, et al.
Blood Purification|August 4, 2011
Absence of anemia in hemodialysis patientsDavid A Goodkin, Douglas S Fuller, Bruce M Robinson, et al.
American Journal of Nephrology|November 7, 2013
Hepatitis C infection is very rarely treated among hemodialysis patientsDavid A Goodkin, Brian Bieber, Brenda Gillespie, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 22, 2010
Hemodialysis vascular access training and practices are key to improved access outcomesDavid A Goodkin, Ronald L Pisoni, Francesco Locatelli, et al.
Pageof 5